 - Use of any oral, implantable, or injectable contraceptive within 30 days or 5 half-lives of the contraceptive whichever is longer prior to first study drug administration; patients must refrain from these types of contraceptives during the treatment period and may resume the use of such contraceptives following the 1-week observation period. 